These findings suggest that the neurotrophin mimetic GK-2,which mainly activates one of the main Trk receptor signaling pathways PI3K/AKT, has a stimulating effect on neurogenesis (and, probably, gliogenesis) andsynaptogenesis in experimental cerebral ischemia. The gene discussed is AKT1; the disease is brain ischemia.